시장보고서

상품코드

1675693

수면무호흡 디바이스 시장 : 제품 유형별, 최종사용자별, 지역별(2025-2033년)

Sleep Apnea Devices Market Report by Product Type (Therapeutic Devices, Diagnostic Devices), End-User (Hospitals and Clinics, Sleep Laboratories, Homecare Settings, and Others), and Region 2025-2033

발행일: 2025년 03월 | 리서치사:

IMARC | 페이지 정보: 영문 140 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 수면무호흡 디바이스 시장 규모는 2024년에 85억 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 144억 달러에 달하며, 2025-2033년의 성장률(CAGR)은 5.72%에 달할 것으로 예측하고 있습니다.

수면무호흡증 또는 수면호흡장애(SDB)는 수면 중 뇌에 산소 공급이 차단되는 급성 질환입니다. 기도가 막혀 불규칙한 호흡 패턴과 큰 코골이, 숨이 차는 증상을 유발합니다. 수면무호흡증후군의 진단 및 치료에는 CPAP(Continuous Positive Airway Pressure), BiPAP(Bilevel Positive Airway Pressure), VPAP(Variable Positive Airway Pressure) 등의 장비가 사용됩니다. Pressure) 등의 장비가 사용되며, 수면 중 환자의 호흡기능 및 기타 신체기능을 평가합니다. 이 외에도 하악전방이동장비(MAD), 혀유지장비 등 다양한 구강내 장비들이 경증에서 중등도의 수면무호흡증 치료에 이용되고 있습니다.

폐쇄성 수면무호흡증(OSA), 중추성 수면무호흡증, 복합형 수면무호흡증의 유병률 증가는 시장 성장을 가속하는 주요 요인 중 하나입니다. 이러한 질병은 노인 인구와 당뇨병, 고혈압, 심혈관 질환(CVDs)과 같은 다른 질병을 앓고 있는 사람들 사이에서 매우 널리 퍼져 있으며, 이는 선진국과 신흥 국가 모두에서 제품 채택을 촉진하고 있습니다. 또한 OSA 진단을 위해 수면 패턴, 심혈관계, 산소포화도, 호흡 매개변수를 검사하는 OOC(Out-of-Center) 검사 장비와 같은 제품 혁신도 또 다른 주요 성장 촉진요인으로 작용하고 있습니다. 의료 인프라의 개선, 수면무호흡증에 대한 인식 증가, 다양한 브랜드의 소형화 및 저렴한 가격대의 기기 출시 등이 시장을 더욱 견인할 것으로 예상됩니다.

이 보고서에서 다룬 주요 질문

2024년 세계 수면무호흡 디바이스 시장 규모는?
2025-2033년 세계 수면무호흡 디바이스 시장의 예상 성장률은?
COVID-19가 전 세계 수면무호흡 디바이스 시장에 미치는 영향은?
세계 수면무호흡 디바이스 시장을 촉진하는 주요 요인은 무엇인가?
전 세계 수면무호흡 디바이스 시장의 제품 유형별 시장 분석은?
세계 수면무호흡 디바이스 시장의 최종사용자별 시장 현황은?
수면무호흡 디바이스 시장의 세계 주요 지역은?
세계 수면무호흡 디바이스 시장의 주요 플레이어/기업은?

북미
- 미국
- 캐나다
유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 인도네시아
- 기타
라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 칠레
- 페루
- 기타
중동 및 아프리카
- 터키
- 사우디아라비아
- 이란
- 아랍에미리트
- 기타

제9장 SWOT 분석

개요
강점
약점
기회
위협

제10장 밸류체인 분석

제11장 Porter's Five Forces 분석

개요
바이어의 교섭력
공급 기업의 교섭력
경쟁의 정도
신규 진출업체의 위협
대체품의 위협

제12장 경쟁 구도

시장 구조
주요 기업
주요 기업의 개요
- BMC Medical Co.
- Braebon Medical Corporation
- Cadwell Laboratories Inc.
- CareFusion Corp.
- Curative Medical Inc.
- Devilbiss Healthcare
- Fisher & Paykel Healthcare
- GE Healthcare
- Invacare
- Oventus Medical
- Panthera Dental
- ResMed
- Somnomed Ltd.
- Vyaire Medical Inc.
- Whole You Inc.

KSA 25.04.14

The global sleep apnea devices market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.

Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.

The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Oral Devices
Nasal Devices
Chin Straps
Others
Diagnostic Devices
Actigraphs
Polysomnography Devices
Sleep Screening Devices
Others

Breakup by End-User:

Hospitals and Clinics
Sleep Laboratories
Homecare Settings
Others

Brealup by Region:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.

Key Questions Answered in This Report

1.What was the size of the global sleep apnea devices market in 2024?
2.What is the expected growth rate of the global sleep apnea devices market during 2025-2033?
3.What has been the impact of COVID-19 on the global sleep apnea devices market?
4.What are the key factors driving the global sleep apnea devices market?
5.What is the breakup of the global sleep apnea devices market based on the product type?
6.What is the breakup of the global sleep apnea devices market based on the end-user?
7.What are the key regions in the global sleep apnea devices market?
8.Who are the key players/companies in the global sleep apnea devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Sleep Apnea Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Therapeutic Devices
- 6.1.1 Market Trends
- 6.1.2 Market Breakup by Type
  - 6.1.2.1 Positive Airway Pressure (PAP) Devices
    - 6.1.2.1.1 Market Trends
    - 6.1.2.1.2 Market Forecast
  - 6.1.2.2 Oral Devices
    - 6.1.2.2.1 Market Trends
    - 6.1.2.2.2 Market Forecast
  - 6.1.2.3 Nasal Devices
    - 6.1.2.3.1 Market Trends
    - 6.1.2.3.2 Market Forecast
  - 6.1.2.4 Chin Straps
    - 6.1.2.4.1 Market Trends
    - 6.1.2.4.2 Market Forecast
  - 6.1.2.5 Others
    - 6.1.2.5.1 Market Trends
    - 6.1.2.5.2 Market Forecast
- 6.1.3 Market Forecast
6.2 Diagnostic Devices
- 6.2.1 Market Trends
- 6.2.2 Market Breakup by Type
  - 6.2.2.1 Actigraphs
    - 6.2.2.1.1 Market Trends
    - 6.2.2.1.2 Market Forecast
  - 6.2.2.2 Polysomnography Devices
    - 6.2.2.2.1 Market Trends
    - 6.2.2.2.2 Market Forecast
  - 6.2.2.3 Sleep Screening Devices
    - 6.2.2.3.1 Market Trends
    - 6.2.2.3.2 Market Forecast
  - 6.2.2.4 Others
    - 6.2.2.4.1 Market Trends
    - 6.2.2.4.2 Market Forecast
- 6.2.3 Market Forecast

7 Market Breakup by End-User

7.1 Hospitals and Clinics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Sleep Laboratories
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Homecare Settings
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Europe
- 8.2.1 Germany
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 France
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 United Kingdom
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 Italy
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Spain
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Russia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Asia Pacific
- 8.3.1 China
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 Japan
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 India
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 South Korea
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Australia
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Indonesia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Argentina
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
- 8.4.4 Colombia
  - 8.4.4.1 Market Trends
  - 8.4.4.2 Market Forecast
- 8.4.5 Chile
  - 8.4.5.1 Market Trends
  - 8.4.5.2 Market Forecast
- 8.4.6 Peru
  - 8.4.6.1 Market Trends
  - 8.4.6.2 Market Forecast
- 8.4.7 Others
  - 8.4.7.1 Market Trends
  - 8.4.7.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Turkey
  - 8.5.1.1 Market Trends
  - 8.5.1.2 Market Forecast
- 8.5.2 Saudi Arabia
  - 8.5.2.1 Market Trends
  - 8.5.2.2 Market Forecast
- 8.5.3 Iran
  - 8.5.3.1 Market Trends
  - 8.5.3.2 Market Forecast
- 8.5.4 United Arab Emirates
  - 8.5.4.1 Market Trends
  - 8.5.4.2 Market Forecast
- 8.5.5 Others
  - 8.5.5.1 Market Trends
  - 8.5.5.2 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Competitive Landscape

12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
- 12.3.1 BMC Medical Co.
  - 12.3.1.1 Company Overview
  - 12.3.1.2 Product Portfolio
- 12.3.2 Braebon Medical Corporation
  - 12.3.2.1 Company Overview
  - 12.3.2.2 Product Portfolio
- 12.3.3 Cadwell Laboratories Inc.
  - 12.3.3.1 Company Overview
  - 12.3.3.2 Product Portfolio
- 12.3.4 CareFusion Corp.
  - 12.3.4.1 Company Overview
  - 12.3.4.2 Product Portfolio
- 12.3.5 Curative Medical Inc.
  - 12.3.5.1 Company Overview
  - 12.3.5.2 Product Portfolio
- 12.3.6 Devilbiss Healthcare
  - 12.3.6.1 Company Overview
  - 12.3.6.2 Product Portfolio
- 12.3.7 Fisher & Paykel Healthcare
  - 12.3.7.1 Company Overview
  - 12.3.7.2 Product Portfolio
  - 12.3.7.3 Financials
- 12.3.8 GE Healthcare
  - 12.3.8.1 Company Overview
  - 12.3.8.2 Product Portfolio
- 12.3.9 Invacare
  - 12.3.9.1 Company Overview
  - 12.3.9.2 Product Portfolio
  - 12.3.9.3 Financials
  - 12.3.9.4 SWOT Analysis
- 12.3.10 Oventus Medical
  - 12.3.10.1 Company Overview
  - 12.3.10.2 Product Portfolio
  - 12.3.10.3 Financials
- 12.3.11 Panthera Dental
  - 12.3.11.1 Company Overview
  - 12.3.11.2 Product Portfolio
- 12.3.12 ResMed
  - 12.3.12.1 Company Overview
  - 12.3.12.2 Product Portfolio
  - 12.3.12.3 Financials
  - 12.3.12.4 SWOT Analysis
- 12.3.13 Somnomed Ltd.
  - 12.3.13.1 Company Overview
  - 12.3.13.2 Product Portfolio
  - 12.3.13.3 Financials
- 12.3.14 Vyaire Medical Inc.
  - 12.3.14.1 Company Overview
  - 12.3.14.2 Product Portfolio
- 12.3.15 Whole You Inc.
  - 12.3.15.1 Company Overview
  - 12.3.15.2 Product Portfolio